CLINICAL_TRIALS
trial_result
· 2014-08-25
Clinical Trial Update: Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation [Phase 3]
Summary
A Phase 3 trial compared ablation of clinical ventricular tachycardia alone versus adding substrate ablation, assessing long-term success of VT ablation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Ventricular Tachycardia | Phase 3 | Status: COMPLETED